Six cases of BRCA1/BRCA2 double heterozygotes were diagnosed with cancers outside of the usual spectrum of breast, ovarian, prostate and pancreatic cancers; three had colorectal cancer, one with gastric cancer, one with endometrial cancer and another with cervical cancer. This evidence concerns the gene BRCA2 and pancreatic neoplasm.